These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 25381817

  • 1. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncogene; 2015 Aug 06; 34(32):4248-59. PubMed ID: 25381817
    [Abstract] [Full Text] [Related]

  • 2. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
    Perry NA, Shriver M, Mameza MG, Grabias B, Balzer E, Kontrogianni-Konstantopoulos A.
    FASEB J; 2012 Jul 06; 26(7):2764-75. PubMed ID: 22441987
    [Abstract] [Full Text] [Related]

  • 3. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.
    Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncotarget; 2016 Jul 19; 7(29):45414-45428. PubMed ID: 27323778
    [Abstract] [Full Text] [Related]

  • 4. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.
    Tuntithavornwat S, Shea DJ, Wong BS, Guardia T, Lee SJ, Yankaskas CL, Zheng L, Kontrogianni-Konstantopoulos A, Konstantopoulos K.
    Cancer Lett; 2022 Feb 01; 526():155-167. PubMed ID: 34826548
    [Abstract] [Full Text] [Related]

  • 5. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells.
    Perry NA, Vitolo MI, Martin SS, Kontrogianni-Konstantopoulos A.
    Oncotarget; 2014 Sep 30; 5(18):8558-68. PubMed ID: 25261370
    [Abstract] [Full Text] [Related]

  • 6. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
    Lombardo Y, Filipović A, Molyneux G, Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yagüe E, Michel L, Coombes RC.
    Proc Natl Acad Sci U S A; 2012 Oct 09; 109(41):16558-63. PubMed ID: 23012411
    [Abstract] [Full Text] [Related]

  • 7. Activation of KRAS promotes the mesenchymal features of basal-type breast cancer.
    Kim RK, Suh Y, Yoo KC, Cui YH, Kim H, Kim MJ, Gyu Kim I, Lee SJ.
    Exp Mol Med; 2015 Jan 30; 47(1):e137. PubMed ID: 25633745
    [Abstract] [Full Text] [Related]

  • 8. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ, Eckel-Mahan KL, McDaniel SM, Prescott JD, Brodsky KS, Tentler JJ, Gutierrez-Hartmann A.
    Oncogene; 2004 Mar 04; 23(9):1766-79. PubMed ID: 14767472
    [Abstract] [Full Text] [Related]

  • 9. Obscurin: A multitasking giant in the fight against cancer.
    Guardia T, Eason M, Kontrogianni-Konstantopoulos A.
    Biochim Biophys Acta Rev Cancer; 2021 Aug 04; 1876(1):188567. PubMed ID: 34015411
    [Abstract] [Full Text] [Related]

  • 10. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS, Kim E, Pon CK, Gill AJ, Moore K, Spillane AJ, Benn DE, Baxter RC.
    Endocr Relat Cancer; 2013 Feb 04; 20(1):1-12. PubMed ID: 23111755
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K, Jiang L, Wang J, Zhang H, Wang X, Cheng D, Dou J.
    J Cancer Res Ther; 2014 Feb 04; 10(4):1063-70. PubMed ID: 25579555
    [Abstract] [Full Text] [Related]

  • 12. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.
    Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639
    [Abstract] [Full Text] [Related]

  • 13. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
    Huo X, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y.
    Oncotarget; 2015 Dec 08; 6(39):41959-75. PubMed ID: 26544623
    [Abstract] [Full Text] [Related]

  • 14. Involvement of Rho GAP GRAF1 in maintenance of epithelial phenotype.
    Regev M, Sabanay H, Kartvelishvily E, Kam Z, Bershadsky AD.
    Cell Adh Migr; 2017 Jul 04; 11(4):367-383. PubMed ID: 27588930
    [Abstract] [Full Text] [Related]

  • 15. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK, Lee DS, Park JC.
    BMC Cancer; 2015 Mar 10; 15():113. PubMed ID: 25879941
    [Abstract] [Full Text] [Related]

  • 16. Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells.
    Andreolas C, Kalogeropoulou M, Voulgari A, Pintzas A.
    Int J Cancer; 2008 Apr 15; 122(8):1745-56. PubMed ID: 18098284
    [Abstract] [Full Text] [Related]

  • 17. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
    Lehtinen L, Ketola K, Mäkelä R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K.
    Oncotarget; 2013 Jan 15; 4(1):48-63. PubMed ID: 23295955
    [Abstract] [Full Text] [Related]

  • 18. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
    Teo WW, Merino VF, Cho S, Korangath P, Liang X, Wu RC, Neumann NM, Ewald AJ, Sukumar S.
    Oncogene; 2016 Oct 20; 35(42):5539-5551. PubMed ID: 27157614
    [Abstract] [Full Text] [Related]

  • 19. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 20; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 20. Rho Guanine Nucleotide Exchange Factor 5 Increases Lung Cancer Cell Tumorigenesis via MMP-2 and Cyclin D1 Upregulation.
    He P, Wu W, Yang K, Tan D, Tang M, Liu H, Wu T, Zhang S, Wang H.
    Mol Cancer Ther; 2015 Jul 20; 14(7):1671-9. PubMed ID: 25777963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.